Evofem Biosciences (EVFM) Gross Profit (2020 - 2026)
Evofem Biosciences (EVFM) reported Gross Profit of $2.12 million for Q2 2026, down 47.9% from $4.07 million a year earlier but up 333.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Gross Profit (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' Gross Profit came in at $13.63 million, down 1.0% year-over-year; for FY2025, it was $15.57 million, up 0.2% from FY2024.
- By year, Gross Profit came in at $15.53 million in FY2024 (+32.7%), $11.71 million in FY2023 (-5.8%), $12.42 million in FY2022 (+196.5%) and $4.19 million in FY2021.
- Five-year quarterly Gross Profit spans a low of -$203,000 in Q4 2022 and a high of $6.97 million in Q4 2025.
- Year over year, Gross Profit gained in six of the last eight quarters, with an average decline of 2.1%.
- The high point for year-over-year Gross Profit in five years was Q3 2022 (growth of 519.7%); the low point was Q2 2023 (a decline of 96.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $489,000 (Q1 2026), $6.97 million (Q4 2025) and $4.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.12 Mn |
| Mar 31, 2026 | 489,000.00 |
| Dec 31, 2025 | 6.97 Mn |
| Sep 30, 2025 | 4.05 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 480,000.00 |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 2.92 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 165,000.00 |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | -203,000.00 |
| Sep 30, 2022 | 4.69 Mn |
| Jun 30, 2022 | 4.75 Mn |
| Mar 31, 2022 | 3.19 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 757,000.00 |
API Access
Evofem Biosciences Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();